European Journal of Clinical Pharmacology

, Volume 25, Issue 5, pp 595–599 | Cite as

Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine

  • U. Gundert-Remy
  • E. Amann
  • R. Hildebrandt
  • E. Weber


The well known interaction between tricyclic antidepressants and the centrally acting antihypertensive drug clonidine, namely impairment of the antihypertensive effect of clonidine, is thought to be related to blockade of noradrenaline uptake or competition at central alpha-receptors. The tetracyclic antidepressant maprotiline has been shown to be a potent inhibitor of noradrenaline uptake and it might, therefore, interfere with the antihypertensive action of clonidine. The possible interaction of clonidine and maprotiline was studied in 8 healthy subjects using doses in the therapeutic range. The study followed a double-blind, cross over design, in which clonidine alone (0.3 mg p.o.), clonidine (0.3 mg p.o.) plus maprotiline (100 mg in 4 divided doses over 22 h), maprotiline alone (100 mg in 4 divided doses over 22 h) and placebo were given by the double-dummy technique. Several pharmacodynamic parameters were measured for 12 h after administration of the drugs (supine and erect blood pressure, heart rate, saliva production and sedation). Concurrent administration of maprotiline did not alter the effect of clonidine and neither the size nor the time of the maximal response after clonidine were influenced by maprotiline. It is concluded that [1] blockade of noradrenaline uptake is not associated with the interaction of tricyclic antidepressants and clonidine, and [2] maprotiline should be preferred to tricyclic antidepressants in hypertensive patients on clonidine therapy if a concomitant depressive illness has to be treated.

Key words

clonidine maprotiline interaction tricyclic antidepressants pharmacodynamic effects 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arndts D, Doevendans J, Kirsten R, Heintz B (1983) New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man. Eur J Clin Pharmacol 24: 21–30Google Scholar
  2. Briant RH, Reid JL (1972) Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Br J Pharmacol 46: 563Google Scholar
  3. Briant RH, Reid JL, Dollery CT (1973) Interaction between clonidine and desipramine. Br Med J 1: 522–523Google Scholar
  4. Briant RH, George CF (1974) The assessment of potential drug interactions with a new tricyclic antidepressant drug Br J Clin Pharmacol 1: 113Google Scholar
  5. Brogden RN, Heel RC, Speight TM, Avery GS (1978) Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16: 273–301Google Scholar
  6. Davies DS, Wing LM, Reid JL, Neill E, Tippet P, Dollery CT (1977) Pharmacokinetics and concentration-effect-relationship of intravenous and oral clonidine. Clin Pharm Ther 21: 593–597Google Scholar
  7. Delbarre B, Schmitt H (1971) Sedative effects of sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol 13: 356–363Google Scholar
  8. Delini-Stula A (1972) The pharmacology of ludiomil. In: Kielholz P (ed) Depressive illness. Diagnosis, assessment, treatment. Huber, Bern, pp 113–124Google Scholar
  9. Dubocovich ML, Langer SZ, Pelayo F (1979) Cocaine and desipramine antagonize the clonidine-induced inhibition of (3H)-noradrenaline release from the rat cerebral cortex. Br J Pharmacol 67: 417–418Google Scholar
  10. Elliot HL, McLean K, Sumner DJ, Reid JL (1981) Pharmacodynamic studies on mianserin and its interaction with clonidine. Eur J Clin Pharmacol 21: 97–102Google Scholar
  11. Elliot HL, McLean K, Sumner DJ, Reid JL (1983) Absence of an effect of mianserin on the action of clonidine or methyldopa in hypertensive patients. Eur J Clin Pharmacol 24: 15–19Google Scholar
  12. Kobinger W, Walland A (1967) Investigations into the mechanism of the hypotensive effect of 2-(2,6- Dichlorphenylamino-)Imidazole-HCL. Eur J Pharmacol 2: 155–162Google Scholar
  13. Maître L, Staehelin M, Bein HJ (1971) Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drug. Biochem Pharmacol 20: 2169Google Scholar
  14. Maxwell C (1978) Sensitivity and accuracy of the visual analogue scale: A psycho-physical classroom experiment. Br J Clin Pharmacol 6: 15–24Google Scholar
  15. Mirakhur RK, Dundee JW, Jones CJ (1978) Evaluation of the anticholinergic actions of glycopyrronium bromide. Br J Anaesth 50: 59–63Google Scholar
  16. Pelayo F, Dubocovich ML, Langer SZ (1980) Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation evoked release of 3H-noradrenaline from rat occipital cortex slices. Eur J Pharmacol 64: 143–155Google Scholar
  17. Pinder RM, Brigden RN, Speight TM, Avery GS (1977) Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13: 321–352Google Scholar
  18. Rand MJ, Rush M, Wilson S (1969) Some observations on the inhibition of salivation by ST 155. Eur J Pharmacol 5: 168–172Google Scholar
  19. Reale A, Motolese M (1972) Haemodynamic studies with Ciba 34276- Ba (Ludiomil). In: Kielholz P (ed) Depressive illness. Diagnosis, assessment, treatment. Huber, Bern, pp 161–168Google Scholar
  20. Reid JL, Briant RH, Dollery CT (1973) Desmethylimipramine and the hyptensive action of clonidine in the rabbit. Life Sci 12: 459–467Google Scholar
  21. Reid JL, Briant RH (1977) An interaction between desmethylimipramine and clonidine. In: Grahame-Smith D (ed). Drug interactions. MacMillan, London, pp 231–238Google Scholar
  22. Sachs L (1978) Angewandte statistik. Springer, Berlin Heidelberg New York, pp 244–246, 422–429Google Scholar
  23. Schmidlin O, Gundert-Remy U, Mäurer W, Weber E (1982) Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R(-)-enantiomer. Br J clin Pharmacol 14: 799–804Google Scholar
  24. Smith AJ, Bant WP (1975) Interactions between post-ganglionic sympathetic blocking drugs and antidepressants. J Int Med Res 3 [Suppl 2]: 55Google Scholar
  25. Van Spanning HW, Van Zwieten PA (1973) The interference of tricyclic antidepressants with the central hypotensive effect of clonidine. Eur J Pharmacol 24: 402–404Google Scholar
  26. Van Zwieten PA (1975) Interaction between centrally acting hypotensive drugs and tricyclic antidepressants. Arch Int Pharmacodyn 214: 12Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • U. Gundert-Remy
    • 1
  • E. Amann
    • 1
  • R. Hildebrandt
    • 1
  • E. Weber
    • 1
  1. 1.Abteilung für Klinische PharmakologieMedizinische UniversitätsklinikHeidelbergFederal Republic of Germany

Personalised recommendations